← Back to Search

PREEMIE PROGRESS Program for Premature Infant Care

N/A
Waitlist Available
Led By Ashley M Weber, PhD, RN, RNC-NIC
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up date of nicu discharge will be assessed until study completion, with maximum of 1 year
Awards & highlights

Study Summary

This trial is testing a new mobile health program to help parents of preterm infants better manage their infant's care.

Who is the study for?
This trial is for English-speaking parents aged 18 or older of preterm infants born between 25 and almost 32 weeks gestation. It's suitable for those who had a single baby or twins. Parents can't join if the mother is too ill to consent, or if their infant is judged by healthcare staff as likely to pass away soon.Check my eligibility
What is being tested?
The PREEMIE PROGRESS program uses mobile health technology and video-based training to help parents manage the complex care needs of their preterm babies in NICU better than standard parenting programs.See study design
What are the potential side effects?
Since this intervention involves educational content rather than medical treatment, traditional side effects are not expected; however, it may impact parental stress levels and coping mechanisms.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~date of nicu discharge will be assessed until study completion, with maximum of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and date of nicu discharge will be assessed until study completion, with maximum of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
NICU Length of Stay
Parent Self-Rating of Anxiety
Parent Self-Rating of Depression
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PREEMIE PROGRESSExperimental Treatment1 Intervention
PREEMIE PROGRESS is an innovative, video-based intervention that applies evidence-based family management theories to better equip parents to meet the chronic, complex healthcare needs of their preterm infant.
Group II: Attention ControlActive Control1 Intervention
To maintain their attention, control parents will view "Welcome Videos" that explain hand hygiene, visitor IDs, parking, etc. on their mobile devices.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PREEMIE PROGRESS
2022
N/A
~70

Find a Location

Who is running the clinical trial?

University of CincinnatiLead Sponsor
428 Previous Clinical Trials
634,322 Total Patients Enrolled
National Institute of Nursing Research (NINR)NIH
579 Previous Clinical Trials
10,376,318 Total Patients Enrolled
1 Trials studying Family Research
30 Patients Enrolled for Family Research
Ashley M Weber, PhD, RN, RNC-NICPrincipal InvestigatorUniversity of Cincinnati

Media Library

PREEMIE PROGRESS Clinical Trial Eligibility Overview. Trial Name: NCT04638127 — N/A
Family Research Research Study Groups: Attention Control, PREEMIE PROGRESS
Family Research Clinical Trial 2023: PREEMIE PROGRESS Highlights & Side Effects. Trial Name: NCT04638127 — N/A
PREEMIE PROGRESS 2023 Treatment Timeline for Medical Study. Trial Name: NCT04638127 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current figure for individuals involved in this research endeavor?

"Affirmative. According to clinicaltrials.gov, an updated version of this trial was released on June 13th 2022 and is currently recruiting 74 individuals at a single medical facility."

Answered by AI

Are there any open slots for participants in this clinical experiment?

"Affirmative. According to the information accessible on clinicaltrials.gov, this medical experiment was first listed online on May 17th 2022 and has since seen updates as recently as June 13th 2022. 74 patients are being sought out at one clinic for enrolment in the trial."

Answered by AI
~22 spots leftby Apr 2025